Organization
University of Sydney
16 clinical trials
Clinical trial
A Multi-centre, Double-blinded, Placebo-controlled, Randomised, Phase II Clinical Trial for Psilocybin-assisted Therapy for Alcohol Use DisorderStatus: Not yet recruiting, Estimated PCD: 2025-07-01
Clinical trial
Randomised Phase 3 Trial of Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer: ENZARADStatus: Active (not recruiting), Estimated PCD: 2024-12-01
Clinical trial
An Investigator Initiated, International Multi-Centre, Multi-Arm, Multi-Stage Randomised Double Blind Placebo Controlled Trial of Angiotensin Receptor Blocker (ARB) & Chemokine Receptor Type 2 (CCR2) Antagonist for the Treatment of COVID-19Status: Terminated, Estimated PCD: 2022-08-15
Clinical trial
Better Evidence and Translation for CalciphylaxisStatus: Recruiting, Estimated PCD: 2029-12-01
Clinical trial
A Randomised Trial to Evaluate the Efficacy of Low-dose Intracoronary Tenecteplase in ST-Elevation Myocardial Infarction (STEMI) Patients With High Microvascular Resistance Post-percutaneous Coronary Intervention (PCI).Status: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Preventing Adverse Outcomes of Neonatal Hypoxic Ischaemic Encephalopathy With Erythropoietin: A Phase III Randomised Placebo Controlled Multicentre Clinical TrialStatus: Completed, Estimated PCD: 2023-11-30
Clinical trial
A Phase I, Double-blind, Dose-ranging, Randomised, Placebo-controlled Trial to Study the Safety and Immunogenicity of a DNA-based Vaccine Against COVID-19 (COVIGEN) in Healthy Participants Aged 18 to 75 Years OldStatus: Completed, Estimated PCD: 2022-07-30
Clinical trial
Fosfomycin Versus Standard of Care in Children With Antibiotic-resistant Urinary Tract Infections: A Non-inferiority, Pragmatic, Multi-centre Adaptive Trial to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of Oral Fosfomycin in Children With Antibiotic-resistant Urinary Tract Infections.Status: Recruiting, Estimated PCD: 2027-08-01
Clinical trial
A Randomised, Controlled Trial of MDMA-assisted Prolonged Exposure Therapy for Comorbid Alcohol Use Disorder and Post-traumatic Stress DisorderStatus: Recruiting, Estimated PCD: 2026-05-01
Clinical trial
Adding Mitomycin to Bacillus of Calmette-Guerin (BCG) as Adjuvant Intravesical Therapy for High-risk, Non-Muscle-invasive Bladder Cancer: a Randomised Phase 3 TrialStatus: Active (not recruiting), Estimated PCD: 2024-12-01
Clinical trial
DASL-HiCaP: Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate (ANZUP1801): A Randomised Phase 3 Double-blind, Placebo-controlled Trial of Adding Darolutamide to Androgen Deprivation Therapy and Definitive or Salvage Radiation in Very High Risk, Clinically Localised Prostate CancerStatus: Active (not recruiting), Estimated PCD: 2028-01-31
Clinical trial
A Randomised Phase II Study of NivolUmab and TeMozolomide vs Temozolomide Alone in Newly Diagnosed Elderly Patients With Glioblastoma (NUTMEG)Status: Active (not recruiting), Estimated PCD: 2024-12-31
Clinical trial
A Phase 2 Trial of Durvalumab (MEDI4736) and Tremelimumab With Chemotherapy in Metastatic EGFR Mutant Non-squamous Non-small Cell Lung Cancer (NSCLC) Following Progression on EGFR Tyrosine Kinase Inhibitors (TKIs)Status: Active (not recruiting), Estimated PCD: 2023-06-30
Clinical trial
A Randomised Controlled Trial of N-acetylcysteine for the Management of Alcohol Use DisorderStatus: Recruiting, Estimated PCD: 2025-11-01
Clinical trial
A Randomised Trial to Evaluate the Efficacy on Retinopathy and Safety of Fenofibrate in Adults With Type 1 Diabetes. A Multicentre Double-blind Placebo-controlled Study in Australia and Internationally.Status: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
A Multicenter Randomized Controlled Trial to Treat Acute t Cell Mediated Rejection in Kidney and Kidney-pancreas Transplant RecipientsStatus: Not yet recruiting, Estimated PCD: 2029-12-01